Position
CAXTON CORP in X4 Pharmaceuticals, Inc
Back to the book · All holders of XFOR
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $2.02K$4.00 → $4.13
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 15.6K | $62.2K | — | — | — | 1.5% |
| Q1 2026 | 15.6K | $64.2K | $4.13 | $2.02K | −$0 | 1.6% |